Company intelligence / Profile preview

MockV Solutions

Rockville, Maryland, United States

Ownership: Private
Development stage: Other

Overview

MockV Solutions developed non-infectious surrogate viral particles (MockV particles) and analytical kits (such as the MockV® RVLP Kit) used by biomanufacturers to optimize and validate the viral clearance capabilities of their purification processes early in development, reducing cost and risk vs. traditional infectious virus studies. The kits and platform are now available via Cygnus Technologies/Maravai LifeSciences.

Industry: Non-Drug Biotech

Partnerships

AGC Biologics

Beyond the preview

Go deeper on MockV Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MockV Solutions.

Explore the full profile